TLR7 and chronic hepatitis B virus infection: Given that observation in addition to the knowledge that IFN-α induction by TLR7 agonists is of high interest during chronic hepatitis B virus infection (47–49), conjugation of TLR7-ligands to cholesterol could be a therapeutical approach.